Inhibition of Men1-deficient tumor growth by inactivation of the Rbp2 histone demethylase

被引：0
|
作者：
Lin, Wenchu [1 ]
Francis, Joshua [1 ]
Watanabe, Hideo [1 ]
Yan, Qin [2 ]
Kaelin, William G. [1 ]
Meyerson, Matthew [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Yale Univ, Sch Med, New Haven, CT USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-62
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
62
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo
    Alimova, Irina
    Pierce, Angela
    Danis, Etienne
    Donson, Andrew
    Birks, Diane K.
    Griesinger, Andrea
    Foreman, Nicholas K.
    Santi, Mariarita
    Soucek, Laura
    Venkataraman, Sujatha
    Vibhakar, Rajeev
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (08) : 1983 - 1995
  • [42] The histone variant macroH2A1 is a splicing-modulated caretaker of genome integrity and tumor growth
    Kim, Jeongkyu
    Oberdoerffer, Philipp
    Khurana, Simran
    MOLECULAR & CELLULAR ONCOLOGY, 2018, 5 (03):
  • [43] RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest
    Lai, A
    Kennedy, BK
    Barbie, DA
    Bertos, NR
    Yang, XJ
    Theberge, MC
    Tsai, SC
    Seto, E
    Zhang, Y
    Kuzmichev, A
    Lane, WS
    Reinberg, D
    Harlow, E
    Branton, PE
    MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (08) : 2918 - 2932
  • [44] Angiopoietin 1/2 inhibition impairs tumor growth in an orthotopic model of renal cell carcinoma
    Orillion, Ashley
    Miles, Kiersten Marie
    Shen, Li
    Adelaiye, Remi
    Ciamporcero, Eric
    Ramakrishnan, Swathi
    Ku, Sheng Yu
    Elbanna, May
    Chintala, Sreenivasulu
    Pili, Roberto
    CANCER RESEARCH, 2014, 74 (19)
  • [45] Mechanisms behind COX-1 and COX-2 inhibition of tumor growth in vivo
    Axelsson, Hans
    Lonnroth, Christina
    Andersson, Marianne
    Lundholm, Kent
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 37 (05) : 1143 - 1152
  • [46] Inhibition of PRL2 Upregulates PTEN and Attenuates Tumor Growth in Tp53-deficient Sarcoma and Lymphoma Mouse Models
    Meke, Frederick Nguele
    Bai, Yunpeng
    Ruiz-Avila, Diego
    Carlock, Colin
    Ayub, Jinan
    Miao, Jinmin
    Hu, Yanyang
    Li, Qinglin
    Zhang, Zhong-Yin
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (01): : 5 - 17
  • [47] Histone demethylase JMJD2D interacts with β-catenin to induce transcription and activate colorectal cancer cell proliferation and tumor growth in mice (vol 156, pg 1112, 2019)
    Kesong, P.
    Lele, K.
    Li, Y.
    GASTROENTEROLOGY, 2021, 160 (04) : 1434 - 1434
  • [48] Design, synthesis, enzyme inhibition, and tumor cell growth inhibition of 2-anilinobenzamide derivatives as SIRT1 inhibitors
    Suzuki, Takayoshi
    Imai, Keiko
    Imai, Erika
    Iida, Shinsuke
    Ueda, Ryuzo
    Tsumoto, Hiroki
    Nakagawa, Hidehiko
    Miyata, Naoki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (16) : 5900 - 5905
  • [49] Human epidermal growth factor receptor 2 inhibits activating transcription factor 7 to promote breast cancer cell migration by activating histone lysine demethylase 1
    Lin, Juli
    Mao, Hehui
    Ji, Zhuannan
    Lin, Weijie
    Wang, Tao
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (05) : 1192 - +
  • [50] Inhibition of tumor growth by ERK1/ 2 inhibitors is associated with the induction of interferon-γ production
    Ma, Xingzhe
    Wang, Qixue
    Duan, Yajun
    Han, Jihong
    FASEB JOURNAL, 2014, 28 (01):
12345